MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B

doi:10.4239/wjd.v16.i4.93630

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-8)

Tables (1-2)

Sum=0

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Apr 15, 2025 (publication date) through Feb 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Apr 15, 2025; 16(4): 93630
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.93630

Full Size Figure Download Figure

Figure 7 Change in the expression of DNA methyl transferase 3A/3B and fibrosis-related molecules in the mice. The expression levels of DNA methyl transferase 3A/3B (DNMT3A/3B), alpha smooth muscle actin (α-SMA), collagen I, and fibronectin in diabetic (db/db) mice treated with agomiR-29a-3p were significantly lower than those in the db/db mice without agomiR-29a-3p treatment (n = 3). CON: Control group; NC: Negative control.

Citation: Yang Y, Chen Y, Tang JY, Chen J, Li GQ, Feng B, Mu J. MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B. World J Diabetes 2025; 16(4): 93630
URL: https://www.wjgnet.com/1948-9358/full/v16/i4/93630.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i4.93630